LAS VEGAS — There are a variety of ways for surgeons to avoid complications with femtosecond laser-assisted cataract surgery, according to a presentation here. H. Burkhard Dick, MD, presented his tips, pearls and hints in preventing complications with femtosecond cataract surgery at the American Academy of Ophthalmology annual meeting.
New therapies being tried in uveual melanoma include combination everolimus, pasireotide long-acting release, and the MEK inhibitor trametinib. Medscape Medical News
LAS VEGAS — OCT is increasingly useful in diagnosing disorders that affect optical pathways to the brain, a speaker told colleagues.“[OCT technology] is really affecting the way that we approach patients and diagnose their problems. Some of them can be life-threatening in neuro-ophthalmology,” Randy H. Kardon, MD, PhD, said during a press briefing on “Innovations in vision: Nanotech, nearsightedness and neuro-ophthalmology imaging.”
Pfizer and Allergan announced today that their boards of directors have approved a definitive merger agreement in which Pfizer will combine with Allergan.The merger has a stock transaction currently valued at $363.63 per Allergan share, for a total value of approximately $160 billion, based on the closing price of Pfizer common stock of $32.18 on Nov. 20, according to a press release from both companies. Under the proposal, the businesses of Pfizer and Allergan will be combined under Allergan plc, which will be renamed Pfizer plc.
LAS VEGAS — At the American Academy of Ophthalmology annual meeting, Nathan M. Radcliffe, MD, discusses how selective laser trabeculoplasty can be a solution to managing glaucoma, both as a primary therapy and as a replacement therapy for eye drops.
CUMMING, Ga.–(BUSINESS WIRE)–Accuitis, Inc. completes latest financing round and elects Geoffrey Meacham PhD to Board of Directors.